Manulife (Manufacturers Life Insurance)
PRVB

Manulife (Manufacturers Life Insurance)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,740
Closed -$596K – 3124
2023
Q1 		$596K Hold
24,740
– – ﹤0.01% 1902
2022
Q4 		$262K Buy
24,740
+354
+1% +$2.86K ﹤0.01% 2391
2022
Q3 		$110K Sell
24,386
-988
-4% -$4.5K ﹤0.01% 2786
2022
Q2 		$101K Buy
25,374
+866
+4% +$4.11K ﹤0.01% 2903
2022
Q1 		$179K Sell
24,508
-7,530
-24% -$45K ﹤0.01% 2815
2021
Q4 		$180 Sell
32,038
-1,303
-4% -$8.27K ﹤0.01% 2927
2021
Q3 		$213K Sell
33,341
-1,287
-4% -$8.27K ﹤0.01% 2940
2021
Q2 		$292K Buy
34,628
+3,575
+12% +$28.8K ﹤0.01% 2833
2021
Q1 		$326K Buy
31,053
+2,197
+8% +$30.9K ﹤0.01% 2565
2020
Q4 		$489K Buy
28,856
+1,608
+6% +$24.1K ﹤0.01% 2210
2020
Q3 		$350K Buy
27,248
+1,749
+7% +$22.1K ﹤0.01% 2188
2020
Q2 		$365K Buy
+25,499
New +$322K ﹤0.01% 2122

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PRVB Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 24,740 shares — an estimated $596K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PRVB in Q2 2020 and held it in 12 quarters. The position peaked at $596K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 24,740 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $596K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Manulife (Manufacturers Life Insurance)'s Provention Bio, Inc. Common Stock position peaked at $596K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.